ATE136469T1 - Neue verwendung eines monoklonalen antikörpers - Google Patents

Neue verwendung eines monoklonalen antikörpers

Info

Publication number
ATE136469T1
ATE136469T1 AT91914884T AT91914884T ATE136469T1 AT E136469 T1 ATE136469 T1 AT E136469T1 AT 91914884 T AT91914884 T AT 91914884T AT 91914884 T AT91914884 T AT 91914884T AT E136469 T1 ATE136469 T1 AT E136469T1
Authority
AT
Austria
Prior art keywords
monoclonal antibody
new use
specificity
fragments
variants
Prior art date
Application number
AT91914884T
Other languages
German (de)
English (en)
Inventor
Hans Loibner
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Application granted granted Critical
Publication of ATE136469T1 publication Critical patent/ATE136469T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT91914884T 1990-08-11 1991-08-08 Neue verwendung eines monoklonalen antikörpers ATE136469T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4025499A DE4025499A1 (de) 1990-08-11 1990-08-11 Verwendung der antikoerper br55-2, deren derivate, konjugate und fragmente zur bekaempfung von hiv-infektionen

Publications (1)

Publication Number Publication Date
ATE136469T1 true ATE136469T1 (de) 1996-04-15

Family

ID=6412074

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91914884T ATE136469T1 (de) 1990-08-11 1991-08-08 Neue verwendung eines monoklonalen antikörpers

Country Status (13)

Country Link
EP (1) EP0547079B1 (enExample)
JP (1) JPH06500771A (enExample)
KR (1) KR930701193A (enExample)
AT (1) ATE136469T1 (enExample)
AU (1) AU657489B2 (enExample)
CA (1) CA2088370C (enExample)
DE (2) DE4025499A1 (enExample)
HU (1) HUT64238A (enExample)
IE (1) IE912823A1 (enExample)
PT (1) PT98622A (enExample)
TW (1) TW223019B (enExample)
WO (1) WO1992003165A1 (enExample)
ZA (1) ZA916313B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE188708T1 (de) * 1991-08-21 2000-01-15 Novartis Ag Antikörperderivate
DK0644947T3 (da) * 1992-05-22 1999-11-01 Novartis Ag Anti-idiotypiske monoklonale antistoffer mod det Lewis Y-specifikke monoklonale antistof BR55-2 og deres anvendelser
ATE249846T1 (de) * 1998-06-29 2003-10-15 Wolfgang Bergter Antivirale und antiretrovirale radioimmunpharmaka auf der basis von alpha- und beta-strahlern

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI873233L (fi) * 1985-11-25 1987-07-23 Cytogen Corp Modifierade virala glykoproteiner.
JPH083487B2 (ja) * 1987-07-31 1996-01-17 株式会社日本抗体研究所 異常応答リンパ球の検出方法並びにこれに用いる検出用試薬及びキット

Also Published As

Publication number Publication date
AU8393291A (en) 1992-03-17
WO1992003165A1 (en) 1992-03-05
AU657489B2 (en) 1995-03-16
KR930701193A (ko) 1993-06-11
DE69118702D1 (de) 1996-05-15
IE912823A1 (en) 1992-02-12
HUT64238A (en) 1993-12-28
DE69118702T2 (de) 1996-09-05
JPH06500771A (ja) 1994-01-27
PT98622A (pt) 1992-06-30
EP0547079A1 (en) 1993-06-23
DE4025499A1 (de) 1992-02-13
CA2088370A1 (en) 1992-02-12
EP0547079B1 (en) 1996-04-10
TW223019B (enExample) 1994-05-01
CA2088370C (en) 2003-03-25
ZA916313B (en) 1993-04-28
HU9300349D0 (en) 1993-05-28

Similar Documents

Publication Publication Date Title
DE69109642D1 (de) Anpassungsfähige Formgebung von Verbundwerkstoffen.
FI955315A0 (fi) HIV:n proteaasin inhibiittoreita, jotka ovat käyttökelpoisia AIDS'n hoitoon
AR001811A1 (es) Anticuerpos anti-icam-1 modificados y su uso en eltratamiento de inflamaciones
ZA946767B (en) Monocional antibodies having property of causing apoptosis.
FI915564A7 (fi) Torkparti.
DE3854502D1 (de) Gegen hiv-antigene spezifischer monoklonaler antikörper.
IT1199735B (it) Anticorpi monoclonali cross reattivi e cross-protettivi contro sierotipi di p.aeruginosa
FI931393A0 (fi) Peptider foer anvaendning vid vaccinering och induktion av neutraliserande motkroppar mot humant immunbristvirus
DE3889062D1 (de) Monoklonaler Antikörper gegen humanen BCDF.
DK0812206T3 (da) Fremgangsmåde til stimulering af en immunrespons
TR200103432T2 (tr) Engelleyici monoklonal VLA-1 antikoru ve enflamasyonlu hastalıkların tedavisinde kullanımı.
DE69841331D1 (de) Humanisierte monoklonale antikörper die schützen gegen shigatoxininduzierte krankheiten
DE69118702D1 (de) Neue verwendung eines monoklonalen antikörpers
YU46858B (sh) Postupak za dobijanje imunoglobulinskih konjugata
ATE155345T1 (de) Gegengift immunsera
DE69129582D1 (de) Antikörper gegen menschlichen plasmin-alpha 2-plasmininhibitor-komplex, hybridoma und immunoassay
FI944563A0 (fi) Mikro-organismeja, valmistusmenetelmä ja käyttö
NO902620L (no) Drivstoff og brenselbehandling.
DK8089D0 (da) Monoclonale antistoffer, deres fremstilling og anvendelse.
DE69434087D1 (de) ENTEROTOXINE VON SHIGELLA FLEXNERI 2a
ATE130200T1 (de) Neue verwendung für einen monoklonalen antikörper.
ATE222927T1 (de) Monoklonaler antikörper gegen den tumorzytotoxischen faktor ii (tcf-ii)
DE69409961D1 (de) Triarylethylenderivate zur therapeutischen verwendung
FR2666576B1 (fr) Procede pour ameliorer les performances et la durabilite des betons.
DE69023717D1 (de) Monoklonaler Antikörper.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties